MX9206149A - N-(mercaptoacil)amino acidos, metodos para su preparcion y uso terapeutico, y composiciones farmaceuticas que los contienen - Google Patents

N-(mercaptoacil)amino acidos, metodos para su preparcion y uso terapeutico, y composiciones farmaceuticas que los contienen

Info

Publication number
MX9206149A
MX9206149A MX9206149A MX9206149A MX9206149A MX 9206149 A MX9206149 A MX 9206149A MX 9206149 A MX9206149 A MX 9206149A MX 9206149 A MX9206149 A MX 9206149A MX 9206149 A MX9206149 A MX 9206149A
Authority
MX
Mexico
Prior art keywords
radical
aryl
preparation
methods
pharmaceutical compositions
Prior art date
Application number
MX9206149A
Other languages
English (en)
Inventor
Fournie-Zaluski
Marie-Claude
Bernard-Pierre Roques
Original Assignee
Inst Nat Sante Rech Med
Rech Medicale Inserm
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Rech Medicale Inserm, Rhone Poulenc Rorer Sa filed Critical Inst Nat Sante Rech Med
Publication of MX9206149A publication Critical patent/MX9206149A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se dirige a un compuesto de la fórmula (I) en donde R representa a un átomo o un radical acilo, arilo o cicloalquil carbonilo o un residuo de la fórmula (Ia), R1 representa un radical alquilo, R2 representa un radical arilo o heteroarilo o R1 representa una cadena de alquileno unida a un átomo de carbono en una posición orto del radical arilo o heteroarilo de R2 relativo a un carbono del radical arilo o heteroarilo de R2 ligado a la porción propanoilo, R3 representa un átomo de hidrógeno o un radical alquilo, arilo alcoxi o ariloxi; y R' representa un átomo de halógeno o un radical alquilo, aralquilo, acilo o aroilo, y las sales farmacéuticamente aceptable del mismo. La invención se dirige también a la preparación de estos compuestos, composiciones farmacéuticas que comprenden los compuestos y métodos para su uso farmacéutico.
MX9206149A 1991-10-25 1992-10-23 N-(mercaptoacil)amino acidos, metodos para su preparcion y uso terapeutico, y composiciones farmaceuticas que los contienen MX9206149A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113174A FR2682952B1 (fr) 1991-10-25 1991-10-25 Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
MX9206149A true MX9206149A (es) 1993-08-01

Family

ID=9418304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206149A MX9206149A (es) 1991-10-25 1992-10-23 N-(mercaptoacil)amino acidos, metodos para su preparcion y uso terapeutico, y composiciones farmaceuticas que los contienen

Country Status (11)

Country Link
EP (2) EP0609310B1 (es)
JP (2) JP3250806B2 (es)
AT (1) ATE168995T1 (es)
AU (1) AU666141B2 (es)
CA (1) CA2121801A1 (es)
DE (1) DE69226443T2 (es)
DK (1) DK0609310T3 (es)
ES (1) ES2118833T3 (es)
FR (1) FR2682952B1 (es)
MX (1) MX9206149A (es)
WO (1) WO1993008162A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
FR2731219B1 (fr) * 1995-03-03 1997-04-25 Bioprojet Soc Civ Procede de synthese d'acides acryliques alpha-substitues et leur application
IT1277737B1 (it) * 1995-12-28 1997-11-12 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
IT1277736B1 (it) * 1995-12-28 1997-11-12 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3467754D1 (de) * 1983-10-03 1988-01-07 Squibb & Sons Inc Enkephalinase inhibitors
FR2617070A2 (fr) * 1987-03-23 1988-12-30 Collet Claude Appareil de prehension, type mandrin, entierement automatique, a commandes d'ouverture et de fermeture ultra-rapides
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
US4879309A (en) * 1988-09-27 1989-11-07 Schering Corporation Mercapto-acylamino acids as antihypertensives

Also Published As

Publication number Publication date
DE69226443T2 (de) 1999-02-04
EP0609310B1 (en) 1998-07-29
FR2682952B1 (fr) 1993-12-03
EP0539848A1 (en) 1993-05-05
AU2789592A (en) 1993-05-21
JP2002030066A (ja) 2002-01-29
WO1993008162A1 (en) 1993-04-29
DK0609310T3 (da) 1999-04-26
CA2121801A1 (en) 1993-04-29
AU666141B2 (en) 1996-02-01
DE69226443D1 (de) 1998-09-03
FR2682952A1 (fr) 1993-04-30
ATE168995T1 (de) 1998-08-15
ES2118833T3 (es) 1998-10-01
EP0609310A1 (en) 1994-08-10
JPH07509441A (ja) 1995-10-19
JP3250806B2 (ja) 2002-01-28

Similar Documents

Publication Publication Date Title
FI831009A0 (fi) Spiro/4(3+n)/-2-aza-3-karboxylsyra-derivat, foerfarande foer deras framstaellning, dessa innehaollaaemnen och deras anvaendning
ATE102193T1 (de) Thiazolidinedionederivate.
PH17740A (en) Substituted acyl derivatives of 1-2,3,4 tetrahydro-isoquinoline-3-carboxylic acids,their pharmaceutical compositions and use
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
MX9304467A (es) Nuevos derivados fosfonados de ariletanolaminas, procedimiento para su preparacion y composiciones farmaceuticas y veterinarias que los contienen.
FI941836A0 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ATE59844T1 (de) Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten.
MX9206149A (es) N-(mercaptoacil)amino acidos, metodos para su preparcion y uso terapeutico, y composiciones farmaceuticas que los contienen
MX9203585A (es) Derivados de fenotiazina y composiciones farmaceuticas que los contienen.
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
DE69011235D1 (de) Derivate von N-(Vincristinyl-23) und N-(Noranhydro-5-vinblastinyl-23) von Amino-1-methylphosphonsäure, ihre Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ZA894399B (en) New derivatives of phenothiazine,their preparation and the compositions which contain them
FR2603035A1 (fr) Nouveaux derives de l'indane, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant